Insulin Glargine and Its Two Active Metabolites: A Sensitive (16 Pm) and Robust Simultaneous Hybrid Assay Coupling Immunoaffinity Purification with LC–MS/MS to Support Biosimilar Clinical Studies
Journal of Chromatography B(2017)
Key words
Insulin glargine and its active metabolites M1 and M2,Immunoaffinity purification (IAP),LC-MS/MS,Hybrid method,Biosimilar clinical studies
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined